Pidd, a new death-domain-containing protein, is induced by p53 and promotes apoptosis

Nature Genetics

Volumn 26, Issue 1, 2000, Pages 122-125

  Lin, Yunping ^a   Ma, Weili ^a   Benchimol, Samuel ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53; PROTEIN PIDD; UNCLASSIFIED DRUG;

APOPTOSIS; ARTICLE; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE; CELL GROWTH; CONTROLLED STUDY; DNA BINDING; DNA DAMAGE; GENE CONTROL; HUMAN; IONIZING RADIATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION;

AMINO ACID SEQUENCE; ANIMALS; APOPTOSIS; BLOTTING, NORTHERN; CARRIER PROTEINS; CELL LINE; CLONING, MOLECULAR; DNA, COMPLEMENTARY; DOSE-RESPONSE RELATIONSHIP, RADIATION; EXPRESSED SEQUENCE TAGS; FRIEND MURINE LEUKEMIA VIRUS; GENES, REPORTER; HUMANS; K562 CELLS; KINETICS; LUCIFERASES; MICE; MOLECULAR SEQUENCE DATA; OLIGONUCLEOTIDES, ANTISENSE; PLASMIDS; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; SEQUENCE HOMOLOGY, AMINO ACID; TEMPERATURE; TIME FACTORS; TISSUE DISTRIBUTION; TRANSFECTION; TRANSFORMATION, GENETIC; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0033812557     PISSN: 10614036     EISSN: None     Source Type: Journal    
DOI: 10.1038/79102     Document Type: Article

References (26)

1. Levine, A.J. p53, the cellular gatekeeper for growth and division. Cell 88, 323-331 (1997).
2. El-Deiry, W.S., Kern, S., Pietenpol, J.A., Kinzler, K.W. & Vogelstein, B. Definition of a consensus binding site for p53. Nature Genet. 1, 45-49 (1992).
3. Crook, T., Marston, N.J., Sara, E.A. & Vousden, K.H. Transcriptional activation by p53 correlates with suppression of growth but not transformation. Cell 79, 817-827 (1994).
4. Pietenpol, J.A. et al. Sequence-specific transcriptional activation is essential for growth suppression by p53. Proc. Natl Acad. Sci. USA 91, 1998-2002 (1994).
5. Michalovitz, D., Halevy, O. & Oren, M. Conditional inhibition of transformation and of cell proliferation by a temperature-sensitive mutant of p53. Cell 62, 671-680 (1990).
6. Johnson, P., Chung, S. & Benchimol, S. Growth suppression of Friend virus-transformed erythroleukemia cells by p53 protein is accompanied by hemoglobin production and is sensitive to erythropoietin. Mol. Cell. Biol. 13, 1456-1463 (1993).
7. Lin, Y. & Benchimol, S. Cytokines inhibit p53-mediated apoptosis but not p53-mediated G1 arrest Mol. Cell. Biol, 15, 6045-6054 (1995).
8. Liang, P. & Pardee, A.B. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. Science 257, 967-971 (1992).
9. Kozak, M. The scanning model for translation: an update. J. Cell Biol. 108, 229-241 (1989).
10. Kobe, B. & Deisenhofer, J. The leucine-rich repeat: a versatile binding motif. Trends Biochem. Sci. 19, 415-421 (1994).
11. El-Deiry, W.S. et al. WAF1, a potential mediator of p53 tumor suppression. Cell 75, 817-825 (1993).
12. Donehower, L.A. et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356, 215-221 (1992).
13. Fu, L., Minden, M.D. & Benchimol, S. Translational regulation of human p53 gene expression. EMBO J. 15, 4392-4401 (1966),
14. Resnick-Silverman, L., St Clair, S., Maurer, M., Zhao, K. & Manfredi, J.J. Identification of a novel class of genomic DNA-binding sites suggests a mechanism for selectivity in target gene activation by the tumor suppressor protein p53. Genes Dev. 12, 2102-2107 (1998).
15. Diller, L. et al. p53 functions as a cell cycle control protein in osteosarcomas. Mol. Cell. Biol. 10, 5772-5781 (1990).
16. Slingerland, J.M., Jenkins, J.R. & Benchimol, S. The transforming and suppressor functions of p53 alleles: effects of mutations that disrupt phosphorylation, oligomerization and nuclear translocation. EMBO J 12, 1029-1037 (1993).
17. Soengas M.S. et al. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition. Science 284, 156-159 (1999).
18. Chomczynski, P. & Sacchi, N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction Anal. Biochem. 162, 156-159 (1987).
19. Mathew, D.H., Burkard, M.E., Freier, S.M., Wyatt, J.R. & Turner, D.H. Predicting oligonucleotide affinity to nucleic acid targets. RNA 5, 1458-1469 (1999).
20. Barry, E.L.R., Gesek, F.A. & Friedman, P.A. Introduction of antisense oligonucleotides into cells by permeabilization with streptolysin O. Biotechniques 15, 1018-1020 (1993).
21. Stanger, B.Z., Leder, P., Lee, T.H., Kim, E. & Seed, B. RIP: a novel protein containing a death domain that interacts with Fas/APO-1 (CD95) in yeast and causes cell death. Cell 81, 513-523 (1995).
22. Chinnaiyan, A.M., O'Rourke, K., Tewari, M. & Dixit, V.M. FADD, a novel death domain-containing protein, interacts with the death domain of Fas and initiates apoptosis. Cell 81, 505-512 (1995).
23. Boldin, M.P. et al. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J. Biol. Chem. 270, 7795-7798 (1995).
24. Ahmad, M. et al. CRADD, a novel human apoptotic adaptor molecule for caspase-2, and FasL/tumor necrosis factor receptor-interacting protein RIP. Cancer Res. 57, 615-619 (1997)
25. Duan, H. & Dixit, V.M. RAIDD is a new 'death' adaptor molecule. Nature 385, 86-89 (1997).
26. Deiss, L.P., Feinstein, E., Berissi, H., Cohen, O. & Kimchi, A. Identification of a novel serine/threonine kinase and a novel 15-kD protein as potential mediators of the γ interferon-induced cell death. Genes Dev. 9, 15-30 (1995).